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Abstract  
To find out the association between Fasting plasma glucose, glycosylated Hemoglobin to macro metals calcium and 
magnesium in a randomly selected 50 patients ( both diabetic and non diabetic) attending the MHC. Comparison of both men 
and women (men= 26, women=24) in the age group of 23 to 72 years were enrolled, Fasting plasma glucose, glycoHb, 
calcium and magnesium were measured using the fasting blood samples.  The parameters were then subjected to 
statistical analysis to find out the relation between any two analytes.  Results of paired t tests with a p of <0.01 was 
considered significant and p<0.001 were considered highly significant to conclude an association between the analytes 
studied. This study has proved beyond doubt that calcium and magnesium are indeed involved in diabetes mellitus both in its 
regulation and glucose metabolism.As the study was carried out during a short period of 1 Month, we were unable to indicate 
control subjects but purely worked out to find the association between FPG, Glycosylated hemoglobin, calcium and 
magnesium.The study recommends that along with glucose and Glycosylated hemoglobin, calcium and magnesium assays 
too should be carried out as additional parameters in the evolution of diabetes mellitus.Based on this study we strongly 
recommend that further research should be carried out to establish the role of calcium and magnesium especially red cell 
calcium and magnesium and diabetes mellitus. 
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INTRODUCTION 
 
Diabetes Mellitus comprises a heterogeneous group of diseases, 
which causes the patients, if untreated to have abnormally high 
plasma glucose levels. Four main types of diabetes Mellitus have 
been defined as type I Insulin dependent Diabetes Mellitus (IDDM),  
type II or non insulin dependent diabetes mellitus (NIDDM), 
Gestational Diabetes, diabetes related to other conditions e.g. 
pancreatic diseases. 
  The forms of Diabetes other than type I or type II are rare. As the 
name indicates, at the time IDDM is diagnosed, the patients are 
totally dependent on exogenous insulin therapy, because all the 
insulin producing beta cells within the pancreas are totally destroyed 
by auto immune diseases. Majority of type I diabetes are diagnosed 
before the age and its incidence increases over age. The prevalence 
of type II is much higher than type I.The incidence of childhood 
diabetes is highest in the world and is rising during the past few 
decades. The number of patients with type II diabetes is also on the 
increase. 
The common organ complications that may develop due to poor 
control of both terms of diabetes mellitus include retinopathy, 
nephropathy, neuropathy, ischemic heart diseases and hypertension.           
Large follow up studies have shown that good glucose control may 
prevent or delay the manifestations of complications despite the long 
duration of disease. Earlier daily or occasional plasma glucose 
determinations were the only way to get information on glucose 
control. These measurements still constitute the basis for day to day 
management of diabetes. Occasional plasma glucose 
measurements can however produce quite variable results 
depending, for instance on the type and timing of insulin injections 
food, drugs and physical exercises(1) 
 
Glycohemaglobin (GHb) 
 
Glycohemaglobin is a blood test that checks the amount of sugar 
(glucose) bound to hemoglobin. Normally, only a small percentage of 
hemoglobin in the blood (4% to 6%) has glucose bound to it.The 
GlycohemaglobinA1c test checks the long term control of blood 
glucose levels in people with diabetes. Most doctors think the 
Glycohemaglobin A1c level is the best way to check how well a 
person is controlling his or her diabetes.(2)The Glycohemaglobin test 
is one blood sample every 3 to 4 months, and the test does not 
change with any recent changes in diet, exercise, or medicines.          
Two main functions of Glycosylated hemoglobin viz HbA1 or HbA1C 
are commonly used in diabetes monitoring. The normal range for 
HbA1C is 4 – 6 % and values for HbA1 is 2 % higher as HbA1C is a 
smaller part of HbA1 levels are below 7.5 % and moderately 
controlled if HbA1C levels vary between 7.5 % - 8.5 % and values 
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from 8.6 % to 10 % indicate poor control of the disease and the 
values over 10% is considered alarmingly high.(3) 
 Glycosylation of serum proteins mainly albumin has also been 
used in diabetes monitoring. The half – life of albumin is 2 – 3 weeks 
and the degree of Glycosylated albumin provides an index of 
glycaemic over shorter period time than HbA1C. one of the most 
widely used measurements of Glycosylated serum proteins is 
fructose amine assay.(4) 
 
Diabetes and Magnesium 
 
Magnesium is an important element for health and disease. It is 
the second most abundant intracellular cation; has been identified as 
a cofactor in over 300 enzymatic reactions involving energy 
metabolism, protein and nucleic acid synthesis. Approximately 50% 
is in soft tissues, the other half in bone and less than 1 % is present 
in blood. The clinical laboratory evaluation of magnesium status is 
limited to the level of magnesium in serum, 24 hour urinary excretion 
and percentage retention following parenteral administration.(5) 
It has been shown that an increase in glucose in blood leads to the 
release, displacement of magnesium from RBC’s thus in the body 
hyper glycemia, high blood glucose, will cause total body magnesium 
deficiency. Magnesium deficiency both extra and intracellular is a 
characteristic of chronic stable mild type II diabetes and may 
predispose to the excess cardiovascular morbidity of the diabetic 
state. Diabetic nephropathy and other complications are most likely 
to be worse as a result of concurrent Magnesium deficiency.(6) 
It has been proved that serum Magnesium level is significantly lower 
in diabetic subjects. 
 
Calcium and Diabetes 
 
In prospective studies, low calcium intake is consistently found to 
be inversely associated with incident type 2DM or the metabolic 
syndrome. In the Nurses Health Study, total (food + supplements) 
calcium intake was inversely associated with incident type 2DM after 
complete multivariate adjustment, including vitamin D intake. A 
similar inverse association was seen in the Black Women’s Health 
Study, a prospective cohort of ~59,000 women aged 21 – 69 at 
baseline.(5) 
Often referred to simply as diabetes is a syndrome characterized 
by disordered metabolism and abnormally high blood sugar 
(hyperglycaemia) resulting from insufficient levels of the 
hormoneinsulin. The characteristic symptoms are excessive urine 
production (polyuria) due to high blood glucose levels, excessive 
thirst and increased fluid intake (polydipsia) attempting to 
compensate for increased urination, blurred vision due to high blood 
glucose effects on the eye's optics, unexplained weight loss, and 
lethargy. These symptoms are likely to be less apparent if the blood 
sugar is only mildly elevated. (5) 
The World Health Organization(10) recognizes three main forms 
of diabetes mellitus: type 1, type 2, and gestational diabetes 
(occurring during pregnancy), which have different causes and 
population distributions. While, ultimately, all forms are due to the 
beta cells of the pancreas being unable to produce sufficient insulin 
to prevent hyperglycemia, the causes are different. Type 1 diabetes 
is usually due to autoimmune destruction of the pancreatic beta cells. 
Type 2 diabetes is characterized by insulin resistance in target 
tissues. This causes a need for abnormally high amounts of insulin 
and diabetes develops when the beta cells cannot meet this demand. 
Prolonged high blood glucose causes glucose absorption, which 
leads to changes in the shape of the lenses of the eyes, resulting in 
vision changes. Blurred vision is a common complaint leading to a 
diabetes diagnosis; type 1 should always be suspected in cases of 
rapid vision change whereas type 2 is generally more gradual, but 
should still be suspected. (11) 
The classical triad of diabetes symptoms is polyuria, polydipsia and 
polyphagia, which are, respectively, frequent urination; increased 
thirst and consequent increased fluid intake; and increased appetite. 
Symptoms may develop quite rapidly (weeks or months) in type 1 
diabetes, particularly in children. However, in type 2 diabetes the 
symptoms develop much more slowly and may be subtle or 
completely absent. Type 1 diabetes may also cause a rapid yet 
significant weight loss (despite normal or even increased eating) and 
irreducible fatigue. All of these symptoms except weight loss can 
also manifest in type 2 diabetes in patients whose diabetes is poorly 
controlled. (12) 
Diabetes can cause many complications. Acute complications 
(hypoglycemia, ketoacidosis, or nonketotic hyperosmolar coma) may 
occur if the disease is not adequately controlled. Serious long-term 
complications include cardiovascular disease (doubled risk), chronic 
renal failure, retinal damage (which can lead to blindness), nerve 
damage (of several kinds), and microvascular damage, which may 
cause impotence and poor healing. Poor healing of wounds, 
particularly of the feet, can lead to gangrene, which may require 
amputation. 
The diagnosis of type 1 diabetes, and many cases of type 2, is 
usually prompted by recent-onset symptoms of excessive urination 
(polyuria) and excessive thirst (polydipsia), often accompanied by 
weight loss. These symptoms typically worsen over days to weeks; 
about a quarter of people with new type 1 diabetes have developed 
some degree of diabetic ketoacidosis by the time the diabetes is 
recognized. The diagnosis of other types of diabetes is usually made 
in other ways. These include ordinary health screening; detection of 
hyperglycemia during other medical investigations; and secondary 
symptoms such as vision changes or unexplainable fatigue. Diabetes 
is often detected when a person suffers a problem that is frequently 
caused by diabetes, such as a heart attack, stroke, neuropathy, poor 
wound healing or a foot ulcer, certain eye problems, certain fungal 
infections, or delivering a baby with macrosomia or hypoglycemia. 
(13) 
Diabetes mellitus is characterized by recurrent or persistent 
hyperglycemia, and is diagnosed by demonstrating any one of the 
following:  
• fasting plasma glucose level at or above 126 mg/dL (7.0 mmol/l).  
• plasma glucose at or above 200 mg/dL (11.1 mmol/l) two hours 
after a 75 g oral glucose load as in a glucose tolerance test.  
• random plasma glucose at or above 200 mg/dL (11.1 mmol/l).  
• Most physicians prefer to measure a fasting glucose level 
because of the ease of measurement and the considerable time 
commitment of formal glucose tolerance testing, which takes two 
hours to complete. According to the current definition, two fasting 
glucose measurements above 126 mg/dL (7.0 mmol/l) is 
considered diagnostic for diabetes mellitus.(14) 
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An elevated level of glucose irreversibly bound to hemoglobin 
(termed glycosylated hemoglobin or HbA1c) of 6.0% or higher (the 
2003 revised U.S. standard) is considered abnormal by most labs; 
HbA1c is primarily used as a treatment-tracking test reflecting 
average blood glucose levels over the preceding 90 days 
(approximately). However, some physicians may order this test at 
the time of diagnosis to track changes over time. The current 
recommended goal for HbA1c in patients with diabetes is <7.0%, 
which is considered good glycemic control, although some guidelines 
are stricter (<6.5%). People with diabetes who have HbA1c levels 
within this range have a significantly lower incidence of complications 
from diabetes, including retinopathy and diabetic nephropathy.(15) 
Many studies have shown that both mean plasma and intracellular 
free magnesium levels are lower in patients with diabetes than in the 
general population. This magnesium deficiency, which may take the 
form of a chronic latent magnesium deficit rather than clinical 
hypomagnesemia, may have clinical importance because the 
magnesium ion is a crucial cofactor for many enzymatic reactions 
involved in metabolic processes.(16) 
Many studies show that mean plasma levels are lower in patients 
with both type 1 and type 2 diabetes compared with non-diabetic 
control subjects. The concentration of intracellular free magnesium in 
erythrocytes is a more sensitive marker in people with diabetes and 
insulin resistance than are plasma levels of magnesium. Decreased 
levels of free intracellular magnesium in erythrocytes have been 
reported in the majority of patients with type 2 diabetes.(17) 
Resnick and associates suggest that extracellular and intracellular 
magnesium deficiency is typical in chronic, stable, mild type 2 
diabetes and may be a strong predisposing factor for the 
development of the excess cardiovascular morbidity associated with 
diabetes. These investigators showed that the levels of serum 
ionized magnesium and erythrocyte intracellular free magnesium 
were significantly lower in 22 untreated patients with type 2 diabetes 
and mild hyperglycemia than they were in 30 healthy control 
subjects(18). Serum total magnesium was not reduced. Among its 
many actions, insulin stimulates the transport of magnesium from the 
extra-cellular to the intracellular compartment. Using atomic 
absorption spectrophotometry and the euglycemichyperinsulinemic 
glucose clamp technique, Paolisso and associates showed that 
plasma magnesium level declined and erythrocyte magnesium levels 
rose significantly (P<.05) in response to insulin in fasting healthy 
adults with no family history of diabetes.(19) 
Reduced magnesium levels in diabetes are caused by several 
factors.  The link between magnesium deficiency and the 
development of diabetes is strengthened by the observation that 
several treatments for type 2 diabetes appear to increase 
magnesium levels. Metformin, for example, raises magnesium levels 
in the liver. Pioglitazone, a thiazolidinedione antidiabetic agent that 
increases insulin sensitivity, increases free magnesium concentration 
in adipocytes.(20) 
Magnesium deficiency is associated with insulin resistance and 
increased platelet reactivity, but studies of oral magnesium 
supplementation and changes in glycemic status or lipid levels in 
diabetes have not been conclusive. Oral magnesium to 20 patients 
with type 2 diabetes, intracellular free magnesium concentration in 
erythrocytes normalized and the increase in platelet reactivity in 
response to thromboxanes decreased significantly. The oral dosage 
was 400 mg / d of elemental magnesium.(21) 
Epidemiologic data suggest that populations with low magnesium 
intake are at increased risk for hypertension, stroke, and other 
manifestations of atherosclerotic disease. In the Atherosclerosis Risk 
in Communities (ARIC) Study, for example, dietary magnesium 
intake was inversely correlated with ultrasonographically measured 
carotid artery wall thickness, which is a surrogate marker for 
atherosclerosis.(22) 
There is evidence to suggest that altered vitamin D and calcium 
homeostasis may play a role in the development of type 2 diabetes. 
The role of vitamin D in type 2 diabetes is suggested by cross-
sectional studies showing that low serum concentrations of 25-
hydroxyvitamin D [25(OH)D] are associated with impaired glucose 
tolerance and diabetes (1-3). The role of calcium in the development 
of type 2 diabetes is suggested indirectly by cross-sectional studies 
in which high calcium intake has been found to be inversely 
associated with body weight and fatness (4-6). The results from 
small clinical trials have been inconsistent (23-28).  
The purpose of the present study was to prospectively evaluate 
the association between vitamin D and calcium intake a Vitamin D 
and calcium insufficiency may negativelyinfluenceglycemia, whereas 
combined supplementation with bothnutrients may be beneficial in 
optimizing glucose metabolismand the risk of type 2 diabetes in a 
large cohort of women followed for 20 years. 
 
Materials and Methods 
 
The subjects selected did not belong to established Diabetes 
mellitus patients, but patients attending the hospital for routine 
master health check up (MHC) in which after our study we found 
patients were found to be diabetic based on the results obtained. 50 
patients comprising of both male and female in the age group of 23 
to 72 years who reported to the outpatient clinic for MHC. The 
subjects selected consisted of 26 males in the age group of 23 to 67 
years and 24 females in  the age group of 17 to 72 years,in order to 
cover our study for a wide range of age and sex related subjects. 
 
Sample Collection & Processing 
Fasting blood sample collection was done between 7- 9am from 
all the patients. Exact sample collection procedures were followed, 
such as use of sterile and disposable needles and vaccutainer for 
collecting the samples.All the blood samples were allowed to clot at 
room temperature for 30 minutes, the tubes were gently tapped to 
displace clot adhering to the tube and then centrifuged with the cap 
on in each tube for 10 minutes at 2500 rpm. Serum from each tube 
was transferred to another set of appropriate labeled tubes using 
disposable plastic dropping pipettes. The samples were either 
analyzed immediately or preserved at 2 - 8˚C if there is a delay in 
analysis. 
The department  is equipped with 2 discrete selective fully 
automatic analyzers (Olympus AU640 and Beckmann AU480)for 
measuring all general chemistries and metals and therefore we 
employed those 2 instruments for analyzing Calcium, magnesium, 
HbA1c and plasma glucose. 
Statistical Analysis 
 For the purpose of statistical calculations like r, t, and probability, 
we have downloaded a software from www.easycalculations.com 
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and comparison were made between Fasting plasma glucose (FPG), 
HbA1C, Ca, Mg and Ca/Mg ratio. 
 Table I presents the statistical data obtained for all the 50 
patients.  Very good correlation (p<0.0001) is observed between all 
the parameters.  Compared, the highest for FPG Vs HbA1C (r=0.91, 
t=15.21 & p=<0.001) indicating that fasting plasma glucose is indeed 
associated with HbA1c.  Similarly both FPG and HbA1C  shows 
good correlation to both calcium and magnesium individually as well 
as to their ratios the highest being with Ca/Mg ratio, suggesting that 
both calcium and magnesium are important for the control of glucose 
metabolism. 
 Table I presents data similar to Tables I&II, but for the 24 female 
patients.  The correlation coefficients, t and p values are identical to 
all patients, but less than that observed for male patients.  One 
more interesting observations in all the three tables is that ; both 
FPG and HbA1c shows negative correlation with magnesium.  This 
may be due to the fact that increase in magnesium level may induce 
better glucose utilization. 
 It is there proved beyond doubt that both FPG and HbA1c are 
indeed associated with both calcium and magnesium.  
Measurements of both calcium and magnesium occasionally may 
help the clinicians to get better information about the overall control 
of both plasma glucose and HbA1c. 
 The results obtained did not indicate either hypo or hyper metals 
concentrations.  As this study was solely to find out the association 
between the 4 analytes, we did not select hypo or hyper calcaemia 
or magnesemia patients. 
Results and Discussion 
Statistical Parameters 
Table I ;All Patients( n = 50) 
 
Some studies have proved positive correlation between  FPG 
and HbA1c and we have confirmed this in ours study. (29)  In 
previous studies delay in estimating plasma glucose after  more 
than 6 hours may have given low values due to deterioration. 
Extensive studies carried out in this aspect during the last 10 
years have proved Glycosylated hemoglobin as a better index than 
fructosamine. We replaced fructosamine with calcium and 
magnesium and our attempt to find a correlation between 
Glycosylated hemoglobin and metals proved positive. Hence, 
calcium and magnesium if done with Glycosylated hemoglobin will 
certainly help to diagnose type II diabetes mellitus. It has been 
suggested that magnesium is associated with diabetes mellitus and 
in our study too we have proved this point with a positive correlation 
of <0.0001, and this same p was obtained when  calcium and 
magnesium are put together as a ratio. 
Several studies have been carried out to find an association 
between zinc, chromium, and magnesium in type II diabetes mellitus. 
But we could not undertake to prove this point as facilities for 
measuring zinc and chromium were currently not available at the 
centre where we undertook this study. Good correlation was 
observed among all the parameters compared namely  FPG, 
Glycosylated hemoglobin, calcium magnesium and their ratios(29). 
It has been conclusively proved that positive predictive tests like 
glycosylated hemoglobin and plasma glucose are very useful to 
diagnose diabetes and our study has proved such an earlier finding. 
The use of glycosylated hemoglobin has been proved as a better 
index of diabetes mellitus(30). 
 
Table II ;Males (n=26) 
 
Table III  Females(n=24) 
 
S.NO PAIRS COMPARED t r p 
1 FPGVs HBA1c 10.75 0.91 <0.0001 
2 FPGVsCa 4.54 0.68 <0.0001 
3 FPGVs Mg 4.19 -0.65 <0.0001 
4 FPGVsCa/Mg 9.57 0.81 <0.0001 
5 HBA1c VsCa 3.31 0.56 0.0015 
6 HBA1c Vs Mg 5.23 -0.73 <0.0001 
7 HBA1c VsCa/Mg 9.57 0.81 <0.0001 
S.NO PAIRS COMPARED t r p 
1 FPGVs HBA1c 15.21 0.91 <0.0001 
2 FPGVsCa 5.93 0.65 <0.0001 
3 FPGVs Mg 5.2 -0.60 <0.0001 
4 FPGVsCa/Mg 8.64 0.78 <0.0001 
5 HBA1c VsCa 5.2 0.6 <0.0001 
6 HBA1c Vs Mg 5.62 -0.63 <0.0001 
7 HBA1c VsCa/Mg 8.36 0.77 <0.0001 
S.N
O 
PAIRS COMPARED t r p 
1 FPGVs HBA1c 10.29 0.91 <0.0001 
2 FPGVsCa 3.81 0.63 <0.0001 
3 FPGVs Mg 3.43 -0.59 <0.0001 
4 FPGVsCa/Mg 8.36 0.77 <0.0001 
5 HBA1c VsCa 3.91 0.64 <0.0001 
6 HBA1c Vs Mg 3.71 -0.62 <0.0001 
7 HBA1c VsCa/Mg 8.64 0.78 <0.0001 
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A study undertaken in UK showed fasting plasma glucose and 
glycosylated hemoglobin correlates well. In our study we have 
proved that elevated HbA1C correlates well with raised fasting 
plasma glucose which is in accordance with an earlier study.In a 
study undertaken in China all three parameter viz fasting plasma 
glucose, glycol HbA1C and fructosamine  were found to correlate 
well.We have assayed magnesium instead of fructosamine and got 
good correlation and concluded that HbA1C, glucose and 
magnesium if done together will help to diagnose type II diabetes 
mellitus.  
It has been suggested that low serum magnesium are related to 
diabetes mellitus and in our study too we have observed majority of 
values are around 2.0 mg/dl and a strong relationship exist between 
plasma glucose and magnesium.Several studies have been carried 
out earlier to find an  association between zinc, magnesium and 
chromium levels in Type II diabetes. 
As there was no facility to measure zinc and chromium, we 
undertook to find out association between magnesium and diabetes 
and its link to plasma glucose and glycosylated hemoglobin. We 
found out strong correlation with P values of < 0.0001 for all the pairs 
of results compared, the best being magnesium and HbA1C.  As 
the project was done in a very short period of 2 weeks we were 
unable to   include control subjects and purely worked out the 
association among biochemical tests used to monitor diabetes with a 
link to magnesium 
Our attempt to include magnesium along with the best available 
diabetes diagnostic biochemical monitors glucose and HbA1C was 
found to be successful and we strongly recommend that serum 
magnesium be included along with the other two diabetic monitors. 
Conclusion 
This study was undertaken  primarily  to find out the 
association between macro metals calcium and magnesium to the 2 
important markers for diabetes mellitus namely fasting plasma 
glucose and Glycosylated haemoglobin.As this study involves only 
relationship  between two macro metals and  two diabetic markers  
we did not select established diabetic patients but  using an 
randomly selected population attending MHC in the hospital.Very 
good correlation between FPG and HbA1c to both calcium and 
Magnesium separately as well as to the ration between them.The 
above observation clearly demonstrate that both calcium and 
magnesium indeed linked to glucose metabolism.The outcome of the 
study  suggests that for every patient who is screened for diabetes 
mellitus it is important  to measure both calcium and 
magnesium.Except  HbA1c assay the other biochemical 
measurements uses inexpensive reagents there by making cost 
effective in doing all the four tests to arrive at a meaningful diagnosis 
to help clinicians for proper treatment and prognosis 
assessment.Further studies are required in this aspect using 
established diabetes mellitus patients to confirm our outcome by 
including trace metals as well as short term diabetic monitoring tests 
such as fructosamine. 
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